Additional file 9 of Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort

Additional file 9. Amplifications with a fold-change ≥ 2 in the 16 tumor tissues analyzed in the study. The 4 potential amplifications with a fold-change ≥ 2 in the 16 tumor tissues analyzed by TruSight™ Oncology 500 panel are shown. In bold is indicated the tumor tissue classified with OncoKB level 1 or Tier IA.